Growth Metrics

Bio Essence (BIOE) Gains from Investment Securities (2021 - 2024)

Bio Essence has reported Gains from Investment Securities over the past 4 years, most recently at $3812.0 for Q2 2024.

  • Quarterly results put Gains from Investment Securities at $3812.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $800.0 (up 700.0% YoY), and the annual figure for FY2025 was $800.0, changed 0.0%.
  • Gains from Investment Securities for Q2 2024 was $3812.0 at Bio Essence, up from -$3012.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BIOE hit a ceiling of $1.6 million in Q3 2023 and a floor of -$1.6 million in Q4 2023.
  • Median Gains from Investment Securities over the past 4 years was $1700.0 (2021), compared with a mean of $700.0.
  • Peak annual rise in Gains from Investment Securities hit 1586763.0% in 2023, while the deepest fall reached 1586763.0% in 2023.
  • Bio Essence's Gains from Investment Securities stood at $3300.0 in 2021, then tumbled by 96.97% to $100.0 in 2022, then plummeted by 1586763.0% to -$1.6 million in 2023, then skyrocketed by 100.24% to $3812.0 in 2024.
  • The last three reported values for Gains from Investment Securities were $3812.0 (Q2 2024), -$3012.0 (Q1 2024), and -$1.6 million (Q4 2023) per Business Quant data.